Letter: Hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma

Y. C. Chen; Y. F. Liaw

doi:10.1111/apt.13674

Letter: Hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma

Y. C. Chen
, Y. F. Liaw

School of Medicine

Chang Gung University

Research output: Contribution to journal › Journal Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	210-211
Number of pages	2
Journal	Alimentary Pharmacology and Therapeutics
Volume	44
Issue number	2
DOIs	https://doi.org/10.1111/apt.13674
State	Published - 01 07 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1111/apt.13674

Cite this

@article{e27222515e4945ae8a10b13a936dfb14,

title = "Letter: Hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma",

author = "Chen, \{Y. C.\} and Liaw, \{Y. F.\}",

year = "2016",

month = jul,

day = "1",

doi = "10.1111/apt.13674",

language = "英语",

volume = "44",

pages = "210--211",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "John Wiley and Sons Inc",

number = "2",

}

TY - JOUR

T1 - Letter

T2 - Hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma

AU - Chen, Y. C.

AU - Liaw, Y. F.

PY - 2016/7/1

Y1 - 2016/7/1

UR - https://www.scopus.com/pages/publications/84974733674

U2 - 10.1111/apt.13674

DO - 10.1111/apt.13674

M3 - 快报

C2 - 27296691

AN - SCOPUS:84974733674

SN - 0269-2813

VL - 44

SP - 210

EP - 211

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 2

ER -

Letter: Hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma

UN SDGs

Access to Document

Other files and links

Cite this